Nicolas Gendron

Publications

Article dans une revue (42)

Quelles pratiques pour un laboratoire de biologie médicale écoresponsable en 2025 ? Marine Cargou,Caroline Sarre-Pradon,Nicolas Gendron,Camille Kolenda,Julien Obiolset al. Revue Francophone des Laboratoires, 2025, 2025 (571), pp.32-44. ⟨10.1016/S1773-035X(25)76346-7⟩ Article dans une revue hal-05039158v1
Relevance of anti–platelet factor 4/heparin antibodies and platelet activation in systemic inflammatory diseases and thrombosis disorders: insight from the COVID-19 pandemic Nicolas Gendron,Dominique Helley,Johannes Thaler,Dorothée Faille,Christine Le Belleret al. Research and Practice in Thrombosis and Haemostasis, 2025, 9 (1), pp.102701. ⟨10.1016/j.rpth.2025.102701⟩ Article dans une revue hal-05121339v1
How to Manage Venous Thromboembolism Risk during Pregnancy in Patients with Inherited Antithrombin Deficiency? Laetitia Mauge,Hugo Madar,Julie Carré,Mathieu Fiore,Nicolas Gendronet al. Thrombosis and Haemostasis, 2025, ⟨10.1055/a-2650-7959⟩ Article dans une revue hal-05216850v1
Building today the sustainable medical biology laboratory of tomorrow Julien Brunier,Marine Cargou,Nicolas Gendron,Camille Kolenda,Bérénice Schellet al. Annales de Biologie Clinique, 2025, 83 (5), pp.477-496. ⟨10.1684/abc.2025.1995⟩ Article dans une revue hal-05322643v1
Safety of venetoclax in real-world experience: data from the French national database of pharmacovigilance through all indications in hematological malignancies over 5 years Alexis Talbot,Pierre-Edouard Debureaux,Agnès Lillo-Le Louet,Yasmine Derri,Marine Aroux-Pavardet al. Therapeutic Advances in Hematology, 2025, 16, ⟨10.1177/20406207251343116⟩ Article dans une revue hal-05308773v1
Interference of oral anti-Xa anticoagulants during monitoring of unfractionated heparin treatments: practical and future attitudes Sophie Melicine,Laure Maucorps,Valérie Eschwège,Julie Carré,Dominique Helleyet al. Annales de Biologie Clinique, 2024, 82 (2), pp.129-138. ⟨10.1684/abc.2024.1873⟩ Article dans une revue hal-05108267v1
Challenges in the Monitoring of Therapeutic Plasma Exchange during Acute Heparin-Induced Thrombocytopenia in Adults under ECMO Nicolas Gendron,Candice Cavalie,Elie Kantor,Sophie Provenchère,Romain Sonnevilleet al. TH Open : Companion Journal To Thrombosis and Haemostasis, 2024, 8 (1), pp.e141-e14. ⟨10.1055/a-2277-4404⟩ Article dans une revue hal-05551999v1
Prospective assessment of the frequency of and risk factors for bleeding events in patients treated with cefazolin Emmanuelle Gras,Yohann Tran,Benjamin Kably,Agnès Lillo-Lelouet,Thibaut Carubaet al. Infection, 2024, 52, pp.557-566. ⟨10.1007/s15010-023-02145-1⟩ Article dans une revue hal-04432550v1
DOAC‐Remove to counteract the interference of anti‐Xa oral anticoagulants on the monitoring of heparin Sophie Melicine,Capucine Habay,Wiame Ghammad,Julie Carré,Jean Luc Diehlet al. International Journal of Laboratory Hematology, 2024, 46 (5), pp.953-962. ⟨10.1111/ijlh.14321⟩ Article dans une revue hal-05108271v1
Is there a role for the laboratory monitoring in the management of specific antidotes of direct oral anticoagulants? Nicolas Gendron,Paul Billoir,Virginie Siguret,Véronique Le Cam Duchez,Valerie Proulleet al. Thrombosis Research, 2024, 237, pp.171-180. ⟨10.1016/j.thromres.2024.04.005⟩ Article dans une revue hal-04567586v1
Evaluation of hemostasis understanding in medical and pharmacy students from a Parisian university Nicolas Gendron,Dominique Helley,Philippe Rousselot,Virginie Siguret,Pascale Gaussemet al. Research and Practice in Thrombosis and Haemostasis, 2024, 8 (6), pp.102547. ⟨10.1016/j.rpth.2024.102547⟩ Article dans une revue hal-04822775v1
Impact of COVID-19 Pandemic on Temporal Trends of Hemostasis Test in France: A Retrospective Analysis of 9 Years of National Health Data Nûn K Bentounes,Richard Chocron,Aurélien Philippe,David M Smadja,Nicolas Gendron TH Open : Companion Journal To Thrombosis and Haemostasis, 2023, 07 (04), ⟨10.1055/a-2165-1249⟩ Article dans une revue hal-05551996v1
Prospective assessment of the frequency of and risk factors for bleeding events in patients treated with cefazolin Emmanuelle Gras,Yohann Tran,Benjamin Kably,Agnès Lillo-Lelouet,Thibaut Carubaet al. Infection, 2023, 52 (2), pp.557-566. ⟨10.1007/s15010-023-02145-1⟩ Article dans une revue hal-05368934v1
Clinical usefulness of admission versus monitoring troponin in patients with coronavirus disease 2019 Agathe Beauvais,Nicolas Gendron,Aurélien Philippe,Benoit Vedie,Marie-Anne Loriotet al. Archives of cardiovascular diseases, 2023, 116 (3), pp.170-172. ⟨10.1016/j.acvd.2022.12.005⟩ Article dans une revue hal-04090823v1
Cancer-Associated Thrombosis on Bevacizumab: Risk of Recurrence and Bleeding When Bevacizumab Is Stopped or Continued Marie Mayenga,Nicolas Falvo,Isabelle Mahé,Anne-Sophie Jannot,Benoit Gazeauet al. Cancers, 2023, 15 (15), pp.3893. ⟨10.3390/cancers15153893⟩ Article dans une revue hal-04362460v1
Daily Monitoring of D-Dimer Allows Outcomes Prediction in COVID-19 David M. Smadja,Olivier Bory,Jean-Luc Diehl,Alexis Mareau,Nicolas Gendronet al. TH Open : Companion Journal To Thrombosis and Haemostasis, 2022, 06 (01), pp.e21-e25. ⟨10.1055/a-1709-5441⟩ Article dans une revue hal-03560901v1
Bleeding risk of intramuscular injection of COVID‐19 vaccines in adult patients with therapeutic anticoagulation Nicolas Gendron,Lina Khider,Christine Le Beller,Benjamin Espinasse,Claire Auditeauet al. Journal of Thrombosis and Haemostasis, 2022, 20 (6), pp.1507-1510. ⟨10.1111/jth.15709⟩ Article dans une revue hal-03866352v1
Adjusting D-dimer to lung disease extent to exclude Pulmonary Embolism in COVID-19 patients (Co-LEAD) Benjamin Planquette,Lina Khider,Alice Le Berre,Simon Soudet,Gilles Pernodet al. Thrombosis and Haemostasis, 2022, 122 (11), pp.1888-1898. ⟨10.1055/a-1768-4371⟩ Article dans une revue hal-03722805v1
Bioprosthetic Total Artificial Heart in Autoregulated Mode Is Biologically Hemocompatible: Insights for Multimers of von Willebrand Factor Bastien Poitier,Richard Chocron,Christophe Peronino,Aurélien Philippe,Yuri Pyaet al. Arteriosclerosis, Thrombosis, and Vascular Biology, 2022, 42 (4), pp.470-480. ⟨10.1161/ATVBAHA.121.316833⟩ Article dans une revue hal-03911974v1
Heparin-induced Thrombocytopenia Diagnosis: A Retrospective Study Comparing Heparin-induced Platelet Activation Test to 14C-serotonin Release Assay Marie-Caroline Gonthier,Nicolas Gendron,Philippine Eloy,Marie-Charlotte Bourrienne,Martine Alhenc-Gelaset al. TH Open : Companion Journal To Thrombosis and Haemostasis, 2021, 05 (04), pp.e507-e512. ⟨10.1055/a-1653-5065⟩ Article dans une revue hal-04434307v1
Type I interferon response and vascular alteration in chilblain‐like lesions during the COVID‐19 outbreak L. Frumholtz,J.‐d. Bouaziz,M. Battistella,J. Hadjadj,R. Chocronet al. British Journal of Dermatology, 2021, 185 (6), pp.1176-1185. ⟨10.1111/bjd.20707⟩ Article dans une revue hal-03892796v1
Anticoagulation prior to hospitalization is a potential protective factor for COVID-19: insight from a French multicenter cohort study Richard Chocron,Vincent Galand,Joffrey Cellier,Nicolas Gendron,Thibaut Pommieret al. Journal of the American Heart Association, 2021, 10 (8), pp.e018288. ⟨10.1161/JAHA.120.018624⟩ Article dans une revue hal-03190837v1
Direct Oral Anticoagulants as Successful Treatment of Heparin-Induced Thrombocytopenia: A Parisian Retrospective Case Series Julie Carré,Hippolyte Guérineau,Christine Le Beller,Laetitia Mauge,Benoit Huynhet al. Frontiers in Medicine, 2021, 8, ⟨10.3389/fmed.2021.713649⟩ Article dans une revue hal-05096767v1
Deterioration of vaccine‐induced immune thrombotic thrombocytopenia treated by heparin and platelet transfusion: Insight from functional cytometry and serotonin release assay Alice Bérezné,David Bougon,Florence Blanc-Jouvan,Nicolas Gendron,Cecile Janssenet al. Research and Practice in Thrombosis and Haemostasis, 2021, 5 (6), ⟨10.1002/rth2.12572⟩ Article dans une revue hal-05551995v1
Prevalence and characteristics of pulmonary embolism in 1042 COVID-19 patients with respiratory symptoms: A nested case-control study Benjamin Planquette,Alice Le Berre,Lina Khider,Alexandra Yannoutsos,Nicolas Gendronet al. Thrombosis Research, 2021, 197, pp.94 - 99. ⟨10.1016/j.thromres.2020.11.001⟩ Article dans une revue hal-03493066v1
Intramuscular Vaccination in Adults with Therapeutic Anticoagulation in the Era of COVID-19 Vaccines Outbreak: A Practical Review Germain Perrin,Christine Le Beller,Luc Darnige,Lina Khider,David Smadjaet al. TH Open : Companion Journal To Thrombosis and Haemostasis, 2021, 05 (02), pp.e166-e170. ⟨10.1055/s-0041-1729627⟩ Article dans une revue hal-03349600v1
Intermediate- vs. Standard-Dose Prophylactic Anticoagulation in Patients With COVID-19 Admitted in Medical Ward: A Propensity Score-Matched Cohort Study David M Smadja,Guillaume Bonnet,Nicolas Gendron,Orianne Weizman,Lina Khideret al. Frontiers in Medicine, 2021, 8, ⟨10.3389/fmed.2021.747527⟩ Article dans une revue hal-03451886v1
Recent Advances in Anticoagulant Treatment of Immune Thrombosis: A Focus on Direct Oral Anticoagulants in Heparin-Induced Thrombocytopenia and Anti-Phospholipid Syndrome Julie Carré,Georges Jourdi,Nicolas Gendron,Dominique Helley,Pascale Gaussemet al. International Journal of Molecular Sciences, 2021, 23 (1), pp.93. ⟨10.3390/ijms23010093⟩ Article dans une revue hal-05096691v1
Platelet activation in critically ill COVID-19 patients Nader Yatim,Jeremy Boussier,Richard Chocron,Jérôme Hadjadj,Aurélien Philippeet al. Annals of Intensive Care, 2021, 11 (1), pp.113. ⟨10.1186/s13613-021-00899-1⟩ Article dans une revue pasteur-03319588v1
Place des anticoagulants oraux directs dans la prise en charge de la maladie thromboembolique veineuse associée au cancer en 2020 Claire Auditeau,Alexis Talbot,Adeline Blandinières,David M. Smadja,Nicolas Gendron Bulletin du Cancer, 2020, 107, pp.574 - 585. ⟨10.1016/j.bulcan.2020.02.010⟩ Article dans une revue hal-03490406v1
Curative anticoagulation prevents endothelial lesion in COVID‐19 patients Lina Khider,Nicolas Gendron,Guillaume Goudot,Richard Chocron,Caroline Hauw‐berlemontet al. Journal of Thrombosis and Haemostasis, 2020, 18 (9), pp.2391-2399. ⟨10.1111/jth.14968⟩ Article dans une revue hal-03677180v1
Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients David Smadja,Coralie Guérin,Richard Chocron,Nader Yatim,Jeremy Boussieret al. Angiogenesis, 2020, pp.1-10. ⟨10.1007/s10456-020-09730-0⟩ Article dans une revue pasteur-02641638v1
Republication de : Quand et quel bilan de thrombophilie réaliser ? N. Gendron,D.M. Smadja,L. Mauge Journal Europeen des Urgences et de Reanimation, 2020, 32, pp.80 - 83. ⟨10.1016/j.jeurea.2020.08.001⟩ Article dans une revue hal-03492648v1
Aplastic anemia related to thymoma: a survey on behalf of the French reference center of aplastic anemia and a review of the literature Nicolas Gendron,Flore Sicre de Fontbrune,Alice Guyard,Jehane Fadlallah,Sylvain Chantepieet al. Haematologica, 2020, 105 (7), pp.e333-e336. ⟨10.3324/haematol.2019.226134⟩ Article dans une revue hal-02962627v1
Quand et quel bilan de thrombophilie réaliser ? N. Gendron,D.M. Smadja,L. Mauge Archives des Maladies du Coeur et des Vaisseaux - Pratique, 2020, 2020, pp.15 - 18. ⟨10.1016/j.amcp.2020.03.008⟩ Article dans une revue hal-03490660v1
Dabigatran Level Before Reversal Can Predict Hemostatic Effectiveness of Idarucizumab in a Real-World Setting Nicolas Gendron,Richard Chocron,Paul Billoir,Julien Brunier,Laurence Camoin-Jauet al. Frontiers in Medicine, 2020, 7, pp.1-11. ⟨10.3389/fmed.2020.599626⟩ Article dans une revue hal-03144498v1
The (Fab)ulous Destiny of Idarucizumab: Highlighting Its Interference with Urine Protein Immunofixation Nicolas Gendron,Héloïse Flament,Elena Litvinova,Sofia Ortuno,Nadine Ajzenberget al. TH Open : Companion Journal To Thrombosis and Haemostasis, 2019, 03 (03), pp.e306-e308. ⟨10.1055/s-0039-1697642⟩ Article dans une revue hal-05558039v1
Pain assessment and factors influencing pain during bone marrow aspiration: A prospective study Nicolas Gendron,Sara Zia Chahabi,Géraldine Poenou,Nadia Rivet,Tiphaine Belleville-Rollandet al. PLoS ONE, 2019, 14 (8), pp.e0221534. ⟨10.1371/journal.pone.0221534⟩ Article dans une revue inserm-02317645v1
Recommandations de bonne pratique pour la prise en charge de la maladie veineuse thromboembolique chez l’adulte. Version courte O. Sanchez,Y. Benhamou,L. Bertoletti,J. Constant,F. Couturaudet al. Revue des Maladies Respiratoires, 2019, 36 (2), pp.249-283. ⟨10.1016/j.rmr.2019.01.003⟩ Article dans une revue hal-02081094v1
Hemocompatibility and safety of the Carmat Total Artifical Heart hybrid membrane Ulysse Richez,Hector de Castilla,Coralie L. Guerin,Nicolas Gendron,Giulia Luraghiet al. Heliyon, 2019, 5, pp.e02914 -. ⟨10.1016/j.heliyon.2019.e02914⟩ Article dans une revue hal-03489284v1
Disseminated toxoplasmosis associated with hemophagocytic syndrome after kidney transplantation: A case report and review Juliette Gay,Nicolas Gendron,Charles Verney,Valentin Joste,Marie‐laure Dardéet al. Transplant Infectious Disease, 2019, pp.213154. ⟨10.1111/tid.13154⟩ Article dans une revue hal-02274839v1
Egfl7 Represses the Vasculogenic Potential of Human Endothelial Progenitor Cells Clément D’audigier,Sophie Susen,Adeline Blandinieres,Virginie Mattot,Bruno Saubameaet al. Stem Cell Reviews and Reports, 2018, 14 (1), pp.82-91. ⟨10.1007/s12015-017-9775-8⟩ Article dans une revue hal-02404172v1

Communication dans un congrès (1)

Blunted vascular response to pulmonary rehabilitation in COPD patients and impaired exercise-induced mobilization of endothelial-colony forming cells Elodie Desplanche,Léo Blervaque,Sven Günther,Maxime Gruest,Aurélien Philippeet al. European Respiratory Society International Congress 2023 (ERS 2023), European Respiratory Society, Sep 2023, Milan, Italy. pp.PA1804, ⟨10.1183/13993003.congress-2023.PA1804⟩ Communication dans un congrès hal-05045329v1